Measure GLUT3 transporter density at synapses using novel PET tracers to provide early biomarker of therapeutic response. Successful neuroprotective interventions should restore synaptic glucose uptake capacity before cognitive improvements become apparent.
Debate provenance: derived from debate `sess_SDA-2026-04-04-SDA-2026-04-04-gap-debate-20260403-222618-c698b06a` on question: Which metabolic biomarkers can distinguish therapeutic response from disease progression in neurodegeneration trials
## Mechanistic Overview
Ketone Utilization Index as Metabolic Flexibility Biomarker starts from the claim that modulating HMGCS2 within the disease context of translational neuroscience can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Ketone Utilization Index as Metabolic Flexibility Biomarker starts from the claim that modulating HMGCS2 within the disease context of translational neuroscience can redirect a disease-relevant process. The original
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
BiomarkerMetabolic Bioenergetics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
Synaptic Glucose Transporter Density as
10/11
dimensions won
Ketone Utilization Index as Metabolic Fl
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
0.70
Evidence
0.55
0.40
Novelty
0.60
0.85
Feasibility
0.00
0.75
Impact
0.00
0.65
Druggability
0.00
0.60
Safety
0.00
0.80
Competition
0.00
0.70
Data
0.00
0.45
Reproducible
0.00
0.35
KG Connect
0.50
0.50
Score Breakdown
Dimension
Synaptic Glucose Transporter D
Ketone Utilization Index as Me
Mechanistic
0.600
0.700
Evidence
0.550
0.400
Novelty
0.600
0.850
Feasibility
0.000
0.750
Impact
0.000
0.650
Druggability
0.000
0.600
Safety
0.000
0.800
Competition
0.000
0.700
Data
0.000
0.450
Reproducible
0.000
0.350
KG Connect
0.500
0.502
Evidence
Synaptic Glucose Transporter Density as an Early Response Bi
No evidence citations yet
Ketone Utilization Index as Metabolic Flexibility Biomarker
No evidence citations yet
Debate Excerpts
Synaptic Glucose Transporter Density as an Early R
4 rounds · quality: 0.92
Persona-Theorist
Based on the provided literature and the identified knowledge gap regarding metabolic biomarkers for neurodegeneration trials, I'll generate novel therapeutic hypotheses. The limited literature focuse...
Persona-Skeptic
I'll critically evaluate each hypothesis, identifying specific weaknesses and providing revised confidence scores. Since the literature provided is quite limited (focusing mainly on sex differences in...
Persona-Domain Expert
## PRACTICAL FEASIBILITY ASSESSMENT
Based on the clinical landscape and druggability analysis, I'll assess the three most viable hypotheses:
### **HYPOTHESIS 5: Lactate/Pyruvate Ratio Dynamics in CS...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker",
"description": "Serial measurements of CSF...
Ketone Utilization Index as Metabolic Flexibility
4 rounds · quality: 0.92
Persona-Theorist
Based on the provided literature and the identified knowledge gap regarding metabolic biomarkers for neurodegeneration trials, I'll generate novel therapeutic hypotheses. The limited literature focuse...
Persona-Skeptic
I'll critically evaluate each hypothesis, identifying specific weaknesses and providing revised confidence scores. Since the literature provided is quite limited (focusing mainly on sex differences in...
Persona-Domain Expert
## PRACTICAL FEASIBILITY ASSESSMENT
Based on the clinical landscape and druggability analysis, I'll assess the three most viable hypotheses:
### **HYPOTHESIS 5: Lactate/Pyruvate Ratio Dynamics in CS...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker",
"description": "Serial measurements of CSF...